Differential expression of collagens type I and type IV lymphangiogenesis during the angiogenic process associated with bleomycin-induced pulmonary fibrosis in rat

Lymphology

Volumn 38, Issue 3, 2005, Pages 130-135

  Teles Grilo, M L ^a   Leite Almeida, H ^a   Martins Dos Santos, J ^b   Oliveira, C ^a   Boaventura, P ^a   Grande, N R ^a  

^a UNIVERSITY OF PORTO   (Portugal)

^b INSTITUTO SUPERIOR DE CIÊNCIAS DA SAÚDE EGAS MONIZ   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; COLLAGEN TYPE 1; COLLAGEN TYPE 4;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGENICITY; ARTICLE; CHRONIC INFLAMMATION; CLARA CELL; CONTROLLED STUDY; DRUG INDUCED DISEASE; EPITHELIUM CELL; IMMUNOCYTOCHEMISTRY; IN SITU HYBRIDIZATION; LUNG FIBROSIS; LYMPHANGIOGENESIS; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; VASCULARIZATION;

EID: 27744441664     PISSN: 00247766     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Oliner, H, R Schwartz, R Rubio, et al: Interstitial pulmonary fibrosis following bisulfan therapy. Am. J. Med. 31 (1961), 134-139.
2. DeLena, M, A Guzzon, S Monfardini, et al: Clinical, radiologic and histopathologic studies on pulmonary toxicity induced by treatment with bleomycin (NSC-125066). Cancer Chemother. Rep. 56 (1972), 343-356.
3. Thrall, RS, JR McCormick, RM Jack, et al: Bleomycin-induced pulmonary fibrosis in the rat. Am. J. Pathology 95 (1979), 117-130.
4. Cooper, J: Pulmonary Fibrosis. Pathways are slowly coming into light. Am. J. Respir. Cell. Mol. Biol. 22 (2000), 520-523.
5. Sousa-Pereira, A, AP Águas, NR Grande, et al: The effect of chronic exposure to low frequency noise on the rat tracheal epithelia. Aviat. Space and Environm. Med. 70 (1999), A86-A90.
6. Phan, SH, J Varani, D Smith: Rat lung fibroblast collagen metabolism in bleomycin-induced pulmonary fibrosis. J. Clin. Invest. 76 (1985), 241-247.
7. Raghow, R, S Lurie, JM Seyer, et al: Profiles of steady state levels of messenger RNAs coding for type I procollagen, elastin and fibronectin in hamster lungs undergoing bleomycin-induced interstitial pulmonary fibrosis. J. Clin. Invest. 76 (1985), 1733-1739.
8. Jackson, JR, MP Seed, CH Kircher, et al: The codependence of angiogenesis and chronic inflammation. FASEB J. 2 (1997), 457-465.
9. Peão, MND, AP Águas, CM de Sá, et al: Neoformation of blood vessels in association with rat lung fibrosis induced by bleomycin. Anat. Record 238 (1993), 57-67.
10. Keane, MP, JA Belperio, BB Moore, et al: Neutralization of the CXC chemokine, macrophage inflammatory protein-2, attenuates bleomycin-induced pulmonary fibrosis. J. Immunol. 162 (1999), 5511-5518.
11. Walsh, DA, CI Pearson: Angiogenesis in the pathogenesis of inflammatory joint and lung diseases. Arthritis Research, 3 (2001), 147-153.
12. Pringle, JH, AK Ruprai, L Primrose, et al: In situ hybridization of immunoglobulin light chain mRNA in paraffin sections using biotinylated or hapten-labelled oligonucleotide probes. J. Pathol. 162 (1990), 197-207.
13. Horton, WA, C Dwyer, R Goering, et al: Immunohistochemistry of types I and II collagen in undecalcified skeletal tissues. J. Histochem. Cytochem. 31 (1983), 417-425.
14. Zhang, K., M. Gharaee-Kermani, B. Garry et al: In situ hybridization analysis of rat lung alpha 1(I) and alpha 2(I) collagen gene expression in pulmonary fibrosis induced by endotracheal bleomycin injection. Lab. Invest. 70 (1994), 192-202.
15. Lee, RT: Lessons from lymph flow-guided vessel formation. Circ. Res. 92 (2003), 701-703.
16. Boardman, KC, MA Swartz: Interstitial flow as a guide for lymphangiogenesis. Circ. Res. 92 (2003), 801-808.
17. Risau, W: Mechanism of angiogenesis. Nature 368 (1997), 671-675.